{"id":973972,"date":"2026-06-19T15:22:05","date_gmt":"2026-06-19T19:22:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/"},"modified":"2026-06-19T15:22:05","modified_gmt":"2026-06-19T19:22:05","slug":"embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/","title":{"rendered":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS"},"content":{"rendered":"
\n

SAN FRANCISCO, June 19, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (NASDAQ: EMBC<\/strong>) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company\u2019s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts\u2019 questions.<\/p>\n

These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws.<\/p>\n

The firm encourages Embecta investors who suffered substantial losses to submit your losses now<\/a>.<\/p>\n

\n Class Period: <\/strong>Nov. 25, 2025 \u2013 May 4, 2026
Lead Plaintiff Deadline: <\/strong>Aug. 17, 2026
Visit:<\/strong>www.hbsslaw.com\/investor-fraud\/embc<\/a>
Contact the Firm Now: <\/strong>EMBC@hbsslaw.com<\/a>
\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 844-916-0895<\/p>\n

\n Embecta Corp. (EMBC) Securities Class Action:<\/strong>\n <\/p>\n

Embecta is a global medical device company whose core business product is pen needles \u2013 sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. In the past, pen needle revenues have comprised over 70% of the company\u2019s total revenues.<\/p>\n

The litigation\u2019s primary focus is on the propriety of Embecta\u2019s Class Period repeated assurances that \u201cinsulin pens have been stable [\u2026] showing the underlying resilience and the durability of that portfolio[]\u201d and \u201cour pen needle business is incredibly resolute.\u201d This narrative formed the basis for the company\u2019s February 5, 2026 guidance reiterating 2026 adjusted EPS of $2.80 – $3.00. The company also touted maintenance of its dividend within its capital allocation plans as a return of capital to shareholders.<\/p>\n

The complaint alleges the company\u2019s assurances and guidance were misleading when given because Embecta knew or recklessly disregarded that weaknesses in the pen needle market was likely to significantly disrupt the company\u2019s annual guidance and Q2 results.<\/p>\n

On May 5, 2026, investors\u2019 expectations vanished. That day, Embecta reported Q2 2026 adjusted EPS of $0.27, a staggering sequential and year-over-year decline of about 61%. In contrast to the company\u2019s assurances of stability, resilience, and durability, Embecta\u2019s pen needles revenues also suffered massive sequential and year-over-year declines. Of additional concern, Embecta slashed its 2026 adjusted EPS guidance to $1.55 – $1.75, or down roughly 43% at the mid-point, and reduced its dividend by 93% to just $0.01.<\/p>\n

In response, the market sent the price of Embecta shares tumbling, with one prominent analyst who downgraded the company highlighting Embecta management\u2019s \u201cneed to rebuild investor credibility on commercial execution and the profitability outlook.\u201d<\/p>\n

\u201cOur investigation is focused the extent to which and when Embecta and its management knew about pen needle and U.S. business revenue headwinds, and whether they were sufficiently transparent about those risks,\u201d said Reed Kathrein<\/strong><\/a>, the Hagens Berman partner leading the firm\u2019s investigation.<\/p>\n

If you invested in Embecta and have substantial losses, or have knowledge that will assist the firm\u2019s investigation, submit your losses now \u00bb<\/a><\/p>\n

If you\u2019d like more information and answers to other frequently asked questions about the firm\u2019s Embecta investigation, read more<\/a> \u00bb<\/a><\/p>\n

\n Whistleblowers: <\/strong>Persons with non-public information regarding Embecta should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895<\/strong> or email EMBC@hbsslaw.com<\/a>.<\/p>\n

\n About Hagens Berman<\/a>
\n
Hagens Berman is a global plaintiffs\u2019 rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman\u2019s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at\u00a0hbsslaw.com<\/a>. Follow the firm for updates and news at\u00a0@ClassActionLaw<\/a>.\u00a0<\/p>\n

\n Contact: <\/u>
\n
Reed Kathrein, 844-916-0895<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO, June 19, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company\u2019s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts\u2019 questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: EMBC@hbsslaw.com\u00a0 … <\/p>\n

Continue reading “Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-973972","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEmbecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, June 19, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company\u2019s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts\u2019 questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: EMBC@hbsslaw.com\u00a0 … Continue reading "Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-19T19:22:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS\",\"datePublished\":\"2026-06-19T19:22:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/\"},\"wordCount\":653,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/\",\"name\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=\",\"datePublished\":\"2026-06-19T19:22:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/","og_locale":"en_US","og_type":"article","og_title":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","og_description":"SAN FRANCISCO, June 19, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company\u2019s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts\u2019 questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: EMBC@hbsslaw.com\u00a0 … Continue reading \"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-19T19:22:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS","datePublished":"2026-06-19T19:22:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/"},"wordCount":653,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/","name":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=","datePublished":"2026-06-19T19:22:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0OTg4MiM3NjcwMTI0IzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=973972"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973972\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=973972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=973972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=973972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}